Amelioration of graft versus host disease by galectin-1 von Baum, Linda G, Blackall, Douglas P, Arias-Magallano, Sarah, Nanigian, Danielle, Uh, Soo Y, Browne, Jordan M, Hoffmann, Douglas, Emmanouilides, Christos E, Territo, Mary C, Baldwin, Gayle Cocita

Volltext

Active Idiotypic Vaccination Versus Control Immunotherapy for Follicular Lymphoma von LEVY, Ronald, GANJOO, Kristen N, NICHOLS, Craig, EMMANOUILIDES, Christos E, TIMMERMAN, John M, GREGORY, Stephanie A, LINK, Brian K, INWARDS, David J, FREEDMAN, Arnold S, MATOUS, Jeffrey V, ROBERTSON, Michael J, KUNKEL, Lori A, LEONARD, John P, INGOLIA, Diane E, GENTLES, Andrew J, CHIH LONG LIU, TIBSHIRANI, Robert, ALIZADEH, Ash A, DENNEY, Dan W, VOSE, Julie M, FLINN, Ian W, AMBINDER, Richard F, CONNORS, Joseph M, BERINSTEIN, Neil L, BELCH, Andrew R, BARTLETT, Nancy L

Volltext

Biosimilars: Hope and concern von Emmanouilides, Christos E, Karampola, Maria I, Beredima, Maria

Volltext

Establishment of an animal model for Waldenström's macroglobulinemia von Tsingotjidou, Anastasia S, Emmanouilides, Christos E, Siotou, Eleni, Poutahidis, Theofilos, Xagorari, Angeliki, Loukopoulos, Panayiotis, Sotiropoulos, Damianos, Bekiari, Chryssa, Doulberis, Michael, Givissis, Panagiotis, Fassas, Athanassios, Anagnostopoulos, Achilles

Volltext

Real life efficacy and safety data of bevacizumab-based front line treatment in advance or metastatic ovarian cancer patients: Focus on patients with malignant ascites—A phase IV s... von Nikolaou, Michail, Ziras, Nikolaos, Athanasiadis, Ilias, Ardavanis, Alexandros, Vaslamatzis, Michael, Kentepozidis, Nikolaos K., Makrantonakis, Paris, Christopoulou, Athina, Michalaki, Vasiliki, Polyzos, Aristidis, Emmanouilides, Christos E., Vardakis, Nikolaos, Kotsakis, Athanasios, Georgoulias, Vassilis

Volltext

Phase II trial of modified FOLIRI plus Panitumumab as first-line treatment in elderly patients with RAS wild-type metastatic colorectal cancer von Karampeazis, Athanasios, Vamvakas, Lampros, Kentepozidis, Nikolaos K., Kotsakis, Athanasios, Kalbakis, Kostas, Xynogalos, Spyros, Sougklakos, Ioannis, Emmanouilides, Christos E., Voutsina, Alexandra, Hatzidaki, Dora, Georgoulias, Vassilis

Volltext

Implications of KRAS status in first line chemotherapy with bevacizumab in advanced colorectal cancer: A phase IV study of Hellenic Oncology Research Group (HORG) von Koumarianou, Anna, Ziras, Nikolaos, Kakolyris, Stylianos, Vaslamatzis, Michael, Polyzos, Aristidis, Kentepozidis, Nikolaos K., Christopoulou, Athina, Xynogalos, Spyros, Athanasiadis, Athanasios, Athanasiadis, Ilias, Anagnostopoulos, Athanasios, Karampeazis, Athanasios, Emmanouilides, Christos E., Boukovinas, Ioannis, Makrantonakis, Paris, Kouroussis, Charalambos, Prinarakis, Efthimios, Hatzidaki, Dora, Georgoulias, Vassilis

Volltext

Three versus six months adjuvant FOLFOX or CAPOX for high risk stage II and stage III colon cancer patients: The efficacy results of Hellenic Oncology Research Group (HORG) partici... von Sougklakos, Ioannis, Boukovinas, Ioannis, Xynogalos, Spyros, Kakolyris, Stylianos, Ziras, Nikolaos, Vaslamatzis, Michael, Athanasiadis, Athanasios, Ardavanis, Alexandros, Androulakis, Nikolaos E. M., Christopoulou, Athina, Makrantonakis, Paris, Bompolaki, Iliada, Christofyllakis, Charalampos, Kentepozidis, Nikolaos K., Emmanouilides, Christos E., Kouroussis, Charalambos, Prinarakis, Efthimios, Kalisperi, Ageliki, Mavroudis, Dimitrios, Georgoulias, Vassilis

Volltext

Three versus six months adjuvant oxaliplatin plus fluoropyrimidine chemotherapy for patients with stage III colon cancer: The Hellenic Oncology Research Group (HORG) participation... von Souglakos, John, Boukovinas, Ioannis, Xynogalos, Spyros, Kakolyris, Stylianos, Ziras, Nikolaos, Vaslamatzis, Michael, Ardavanis, Alexandros, Athanasiadis, Athanasios, Androulakis, Nikolaos E. M., Kentepozidis, Nikolaos K., Christopoulou, Athina, Makrantonakis, Paris, Varthalitis, Ioannis I., Christofyllakis, Charalampos, Emmanouilides, Christos E., Mavroudis, Dimitrios, Prinarakis, Efthimios, Kalisperi, Aggeliki, Hatzidaki, Dora, Georgoulias, Vassilis

Volltext

Leptospirosis Complicated by a Jarisch-Herxheimer Reaction and Adult Respiratory Distress Syndrome: Case Report von Emmanouilides, Christos E., Kohn, Orly F., Garibaldi, Richard

Volltext

Efficacy and safety of sequential use of everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC) previously treated with bevacizumab (BEV) with or without in... von Thiery-Vuillemin, Antoine, Theodore, Christine, Jacobasch, Lutz, Schmitz, Jorg, Guillot, Aline, Papandreou, Christos, Emmanouilides, Christos E., Kim, Stefano Chong Hun, Ktiouet, Meryem, Kelkouli, Nadia, Nguyen, Thierry

Volltext

Pasteurella multocida Bacteremia in a Leukopenic Cancer Patient von Lee, Brian L, Emmanouilides, Christos E

Volltext

Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers von Spielberger, Ricardo, Stiff, Patrick, Bensinger, William, Gentile, Teresa, Weisdorf, Daniel, Kewalramani, Tarun, Shea, Thomas, Yanovich, Saul, Hansen, Keith, Noga, Stephen, McCarty, John, LeMaistre, C. Frederick, Sung, Eric C, Blazar, Bruce R, Elhardt, Dieter, Chen, Mon-Gy, Emmanouilides, Christos

Volltext

Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicu... von WITZIG, Thomas E, GORDON, Leo I, GRILLO-LOPEZ, Antonio J, MULTANI, Pratik, WHITE, Christine A, CABANILLAS, Fernando, CZUCZMAN, Myron S, EMMANOUILIDES, Christos, JOYCE, Robin, POHLMAN, Brad L, BARTLETT, Nancy L, WISEMAN, Gregory A, PADRE, Norman

Volltext

Treatment With Ibritumomab Tiuxetan Radioimmunotherapy in Patients With Rituximab-Refractory Follicular Non-Hodgkin’s Lymphoma von WITZIG, Thomas E, FLINN, Ian W, WHITE, Christine A, GORDON, Leo I, EMMANOUILIDES, Christos, CZUCZMAN, Myron S, SALEH, Mansoor N, CRIPE, Larry, WISEMAN, Gregory, OLEJNIK, Teresa, MULTANI, Pratik S

Volltext

Polymorphisms in FcγRIIIA (CD16) Receptor Expression Are Associated With Clinical Response to Rituximab in Waldenström’s Macroglobulinemia von TREON, Steven P, HANSEN, Mark, MALONEY, David G, FOX, Edward A, BRANAGAN, Andrew R, VERSELIS, Sigitas, EMMANOUILIDES, Christos, KIMBY, Eva, FRANKEL, Stanley R, TOUROUTOGLOU, Nikolaos, TURNBULL, Barry, ANDERSON, Kenneth C

Volltext

Safety of Yttrium-90 Ibritumomab Tiuxetan Radioimmunotherapy for Relapsed Low-Grade, Follicular, or Transformed Non-Hodgkin’s Lymphoma von WITZIG, Thomas E, WHITE, Christine A, GORDON, Leo I, WISEMAN, Gregory A, EMMANOUILIDES, Christos, MURRAY, James L, LISTER, John, MULTANI, Pratik S

Volltext

Treatment-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Patients Treated With Ibritumomab Tiuxetan Radioimmunotherapy von CZUCZMAN, Myron S, EMMANOUILIDES, Christos, DARIF, Mohamed, WITZIG, Thomas E, GORDON, Leo I, REVELL, Stephen, VO, Katie, MOLINA, Arturo

Volltext

Phase I/II Study of Galiximab, an Anti-CD80 Antibody, for Relapsed or Refractory Follicular Lymphoma von CZUCZMAN, Myron S, THALL, Aron, SWEETENHAM, John, ALKUZWENY, Baha, FINUCANE, Deborah M, LEIGH, Bryan R, WITZIG, Thomas E, VASE, Julie M, YOUNES, Anas, EMMANOUILIDES, Christos, MILLER, Thomas P, MOORE, Joseph O, LEONARD, John P, GORDON, Leo I

Volltext

Phase I/II Trial of IDEC-Y2B8 Radioimmunotherapy for Treatment of Relapsed or Refractory CD20+ B-Cell Non-Hodgkin's Lymphoma von WITZIG, T. E, WHITE, C. A, SILVERMAN, D. H. S, PARKER, E, GRILLO-LOPEZ, A. J, WISEMAN, G. A, GORDON, L. I, EMMANOUILIDES, C, RAUBITSCHEK, A, JANAKIRAMAN, N, GUTHEIL, J, SCHILDER, R. J, SPIES, S

Volltext